MedPath

STOP? II: Testing of a Toolbox for Structured Communication in the Operating Room

Not Applicable
Recruiting
Conditions
Communication, Multidisciplinary
Communication Research
Interventions
Behavioral: StOP?-protocol
Registration Number
NCT05356962
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Brief Summary

The purpose of the study is to test the impact of the StOP?-protocol - an intra-operative communication briefing, on post-operative mortality and important patient outcomes.

Detailed Description

The StOP?-protocol is a communication briefing initiated by the responsible surgeon during a surgical operation. The surgeon informs the team present in the operating room about the current Status of the operation, the Objectives of the next steps and the potential Problems the surgical team may meet; the responsible surgeon encourages the team to voice any question or concern (?).

To test the impact of the StOP?-protocol on patient outcomes, the study is designed as a randomized controlled trial. Surgeons will be randomized either (a) in the intervention group and be trained to perform the StOP?-protocol or (b) in the control group and will communicate as they prefer during their operations. Post-operative patient outcomes of the surgeons in the intervention and the control group will be compared to evaluate the effects of the StOP?-protocol.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
400
Inclusion Criteria
  • Board-certified surgeons with specialization in one of the following disciplines: general, visceral, thoracic, vascular surgery, surgical urology, or gynecology.
Exclusion Criteria
  • Surgeons who are already performing StOP?-protocol. (Potentially, surgeons who took part in the first study (StOP-I) may still perform StOP?).
  • Surgeon who were previously enrolled in the StOP?-II trial (this is relevant for surgeons who move or rotate between departments/hospitals and might therefore be working at different participating sites).

For the patients:

Inclusion criteria:

  • Patients operated by cluster surgeons during the cluster-specific time period
  • General consent from the patients, allowing the use of healthcare-related data that are the result of the patient's treatment. In case no written document from the general consent is available despite documented efforts of the participating center, article 34 HRA (Swiss law) will be applied, allowing the use of the healthcare-related patient data.

Exclusion criteria:

  • Patient age below 18 years
  • Previous operation at the same site up to 30 days prior the index operation
  • Procedures not done in operating rooms but in outpatient clinics, on wards, etc.
  • Mainly diagnostic endoscopic procedures (e.g. colonoscopy, gastroscopy, bronchoscopy)
  • Percutaneous interventions (e.g., transurethral interventions)
  • Documented refusal for the use of healthcare related data

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Interventional groupStOP?-protocolThe surgeons will undergo a multi-module training on how to use the StOP?-protocol and perform the StOP?-protocol during all their operations during a 4-month period.
Primary Outcome Measures
NameTimeMethod
Mortality within 30 days after the operation30 days after the index operation

Mortality within 30 days after the operation in the intervention arm compared to the control arm

Secondary Outcome Measures
NameTimeMethod
Unplanned hospital readmissions within 30 days after the operation30 days after the index operation

Unplanned hospital readmissions within 30 days after the operation in the intervention arm compared to the control arm

Unplanned reoperations within 30 days after the operation30 days after the index operation

Unplanned reoperations within 30 days after the operation in the intervention arm compared to the control arm

Length of hospital stayIt is reasonable to estimate that the information will be available after 60 post-operative days for most patients

Length of hospital stay in the intervention arm compared to the control arm

Trial Locations

Locations (11)

Tirol Kliniken GmbH

🇦🇹

Innsbruck, Austria

Centre Hospitalier Universitaire Vaudois (CHUV)

🇨🇭

Lausanne, Vaud, Switzerland

Stadtspital Zürich Triemli

🇨🇭

Zürich, ZH, Switzerland

Bern University Hospital (Inselspital)

🇨🇭

Bern, BE, Switzerland

Kantonsspital Baselland

🇨🇭

Liestal, BL, Switzerland

Kantonsspital Graubünden

🇨🇭

Chur, GR, Switzerland

Hôpital Fribourgeois

🇨🇭

Fribourg, FR, Switzerland

Spital Thurgau

🇨🇭

Frauenfeld, Thurgau, Switzerland

Spital Limmattal

🇨🇭

Schlieren, ZH, Switzerland

Kantonsspital Winterthur

🇨🇭

Winterthur, ZH, Switzerland

Réseau hospitalier neuchâtelois

🇨🇭

Neuchâtel, Switzerland

© Copyright 2025. All Rights Reserved by MedPath